What does this video actually claim?
Jarosław Sroka tells his 25.6K Instagram viewers that TB-500, also called thymosin beta-4, is a peptide that "revolutionizes" tissue regeneration. He claims it works at the cellular level to stimulate cell migration and stem cell differentiation, accelerating healing of muscles, tendons, skin, and even internal organs while reducing inflammation and pain.
The post uses typical biohacking language about "discovering the power of regeneration" and positions TB-500 as a solution for faster healing and post-injury support. It's part of a broader trend of wellness influencers promoting research peptides as performance enhancers.
Does the science back this up?
The research on thymosin beta-4 is limited and mostly comes from animal studies. A 2012 study by Sosne et al. in Experimental Eye Research showed TB-500 improved corneal wound healing in mice. Another study by Bock-Marquette et al. (Nature, 2004) found it promoted cardiac cell survival after heart injury in mouse models.
But here's the problem: these were small animal studies, not human clinical trials. The handful of human studies that exist focus on very specific medical conditions like dry eye disease, not general "regeneration" or athletic recovery.
The FDA hasn't approved TB-500 for any therapeutic use. It's sold as a "research chemical" in a regulatory gray area that lets influencers make sweeping health claims without the evidence to back them up.
What did Sroka get wrong?
Sroka's biggest error is presenting TB-500 as an established therapeutic option when it's still experimental. He talks about stem cell differentiation and tissue regeneration like these effects are proven in humans, but they're not.
The claim about healing "internal organs" is particularly problematic. While thymosin beta-4 showed some promise for cardiac repair in mouse studies, extrapolating that to broad organ healing in humans is a huge leap.
He also doesn't mention any risks or side effects. TB-500 can cause injection site reactions, and some researchers worry about its potential to promote tumor growth, though this hasn't been definitively proven.
What's the regulatory reality?
TB-500 exists in a legal gray zone that confuses consumers. It's not a dietary supplement, and it's not an approved drug. Companies sell it labeled "for research purposes only" to avoid FDA oversight.
The World Anti-Doping Agency banned TB-500 in 2010 because of its potential performance-enhancing effects. Several athletes, including multiple Olympic medalists, have tested positive for it.
This regulatory status matters because it means there's no quality control, standardized dosing, or safety monitoring. You're essentially participating in an uncontrolled experiment when you use it.
What should you actually know?
TB-500 might have therapeutic potential, but we're years away from knowing if it's safe and effective in humans. The animal research is interesting but preliminary.
If you're dealing with an injury or slow healing, proven treatments exist. Physical therapy, proper nutrition, adequate sleep, and time usually work better than experimental peptides.
Influencers like Sroka aren't required to disclose whether they're selling these peptides or getting kickbacks from companies that do. That financial incentive should make you skeptical of their claims.